{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:30:12Z","timestamp":1773927012578,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T00:00:00Z","timestamp":1389571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jnci.2014.01.001","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T11:08:43Z","timestamp":1391339323000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Iman A.","family":"Abd El Gawad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada I.","family":"Mossallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha H.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba M.","family":"Elzawahry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niveen M.","family":"Elhifnawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.jnci.2014.01.001_b0005","first-page":"105","article-title":"Molecular genetics of hepatocellular neoplasia","volume":"2","author":"Jain","year":"2010","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jnci.2014.01.001_b0010","unstructured":"NCI Cancer Registry, Cairo: Cancer Registry, 2002\u20132007. Website: http:\/\/www.nci.edu.eg.data."},{"issue":"S1","key":"10.1016\/j.jnci.2014.01.001_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000122603","article-title":"Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma","volume":"51","author":"Sakamoto","year":"2008","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.jnci.2014.01.001_b0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alfa-feto protein, des-gamma carboxy prothrombin, and lectin-bound alpha-feto protein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jnci.2014.01.001_b0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum AFP for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HbSAg and anti-HCV status","volume":"34","author":"Treviasiani","year":"2001","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jnci.2014.01.001_b0030","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.1840120625","article-title":"Alpha-fetoprotein (reevaluation in hepatology)","volume":"12","author":"Taketa","year":"1990","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jnci.2014.01.001_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1089-3261(05)70158-6","article-title":"The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma","volume":"5","author":"Johnson","year":"2001","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.jnci.2014.01.001_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/PAP.0b013e3181992455","article-title":"Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more","volume":"16","author":"Kandil","year":"2009","journal-title":"Adv Anat Pathol"},{"issue":"35","key":"10.1016\/j.jnci.2014.01.001_b0045","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.3748\/wjg.v16.i35.4410","article-title":"Diagnostic value of Glypican-3 in serum and liver for primary hepatocellular carcinoma","volume":"16","author":"Liu","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jnci.2014.01.001_b0050","first-page":"41","article-title":"Clinical utility of Glypican-3 in hepatocellular carcinoma","volume":"10","author":"Youssef","year":"2010","journal-title":"Int J Integr Biol"},{"issue":"Suppl.","key":"10.1016\/j.jnci.2014.01.001_b0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000315228","article-title":"Molecular signature of early hepatocellular carcinoma","volume":"78","author":"Suriawinata","year":"2010","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.jnci.2014.01.001_b0060","first-page":"105","article-title":"The diagnostic value of peripheral blood Glypican-3 in patients with hepatocellular carcinoma","volume":"7","author":"Gomaa","year":"2012","journal-title":"World J Med Sci"},{"key":"10.1016\/j.jnci.2014.01.001_b0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0046-8177(74)80061-4","article-title":"Carcinoembryonic antigen (CEA) assay: a laboratory adjunct in the diagnosis and management of cancer","volume":"5","author":"Hansen","year":"1974","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jnci.2014.01.001_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-2007-3202","article-title":"Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3","volume":"3","author":"Volk","year":"2007","journal-title":"Cancer Biomarkers"},{"issue":"3","key":"10.1016\/j.jnci.2014.01.001_b0075","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12072-010-9186-2","article-title":"Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population","volume":"4","author":"Sharma","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jnci.2014.01.001_b0080","unstructured":"Zachary, Khodeer S, Ezzat H, Abdel Malak C. Impact of PIVKA-II in diagnosis of hepatocellular carcinoma. International Conference on Ecological, Environmental and Biology Sciences (ICEEBS\u2019 2012), Jan. 7\u20138. 2012 Dubai."},{"issue":"3","key":"10.1016\/j.jnci.2014.01.001_b0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3748\/wjg.v19.i3.339","article-title":"Diagnostic value of AFP and PIVKA-II in HCC according to total-AFP","volume":"19","author":"Choi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jnci.2014.01.001_b0090","unstructured":"Poller L. The prothrombin time 1998; World Health Organization\/Health Laboratory Technology unit LAB\/98.3. http:\/\/www.who.int\/iris\/handle\/10665\/63996."},{"issue":"2","key":"10.1016\/j.jnci.2014.01.001_b0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1073\/pnas.70.2.526","article-title":"Radioimmunoassay for Human Alpha-1 Fetoprotein","volume":"70","author":"Silver","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jnci.2014.01.001_b0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/clinchem\/35.1.146","article-title":"Solving the problem of antibody interference in commercial \u201csandwich\u201d-type immunoassays of carcinoembryonic antigen","volume":"35","author":"Hansen","year":"1989","journal-title":"Clin Chem"},{"issue":"10 Suppl 2","key":"10.1016\/j.jnci.2014.01.001_b0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1542-3565(05)00705-6","article-title":"Tracing the evolution of hepatitis C virus in the United States, Japan and Egypt by using the molecular clock","volume":"3","author":"Mizokami","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jnci.2014.01.001_b0110","first-page":"241","article-title":"Specific markers in hepatocellular carcinoma","volume":"6","author":"Yao","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"10.1016\/j.jnci.2014.01.001_b0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-291X(03)00908-2","article-title":"Glypican 3, overexpressed specifically in human hepatocellular carcinoma is a novel tumor marker","volume":"306","author":"Nakatsura","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.jnci.2014.01.001_b0120","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2008.85","article-title":"Utility and limitation of Glypican-3 expression for the of hepatocellular carcinoma at both ends of the differentiation spectrum","volume":"21","author":"Shafizadeh","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jnci.2014.01.001_b0125","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-03-2191","article-title":"Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma","volume":"64","author":"Hippo","year":"2004","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.jnci.2014.01.001_b0130","first-page":"1333","article-title":"Expression pattern of glypican-3 (GPC-3) during human embryonic and fetal development","volume":"23","author":"Iglesias","year":"2008","journal-title":"Histol Histopathol"},{"issue":"5","key":"10.1016\/j.jnci.2014.01.001_b0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jcla.20484","article-title":"Diagnostic and prognostic role of serum glypican3 in patients with hepatocellular carcinoma","volume":"25","author":"Ozkan","year":"2011","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"10.1016\/j.jnci.2014.01.001_b0140","first-page":"32","article-title":"Diagnotic role of serum Glypican-3 as a tumor marker for hepatocellular carcinoma","volume":"10","author":"El-Shenawy","year":"2012","journal-title":"Nat Sci"},{"issue":"2","key":"10.1016\/j.jnci.2014.01.001_b0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-200108000-00006","article-title":"The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients","volume":"33","author":"Hassan","year":"2001","journal-title":"J Clin Gastroenterol"},{"issue":"35","key":"10.1016\/j.jnci.2014.01.001_b0150","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.3748\/wjg.v16.i35.4410","article-title":"Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma","volume":"16","author":"Liu","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jnci.2014.01.001_b0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jnci.2014.01.001_b0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MCG.0b013e318182015a","article-title":"Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study","volume":"43","author":"Kim","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"91\u201392","key":"10.1016\/j.jnci.2014.01.001_b0165","first-page":"763","article-title":"Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP","volume":"56","author":"Baek","year":"2009","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.jnci.2014.01.001_b0170","first-page":"116","article-title":"Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence","volume":"82","author":"Singhal","year":"2012","journal-title":"Oncol Hematol"},{"issue":"7","key":"10.1016\/j.jnci.2014.01.001_b0175","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/carcin\/bgn091","article-title":"Glypican-3-mediated oncogenesis involves the insulin-like growth factor-signaling pathway","volume":"29","author":"Cheng","year":"2008","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.jnci.2014.01.001_b0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexmp.2006.10.010","article-title":"Glypican-3 from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma","volume":"82","author":"Jackbovic","year":"2007","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"10.1016\/j.jnci.2014.01.001_b0185","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3748\/wjg.v12.i8.1175","article-title":"Serum tumor markers for detection of hepatocellular carcinoma","volume":"12","author":"Zhou","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jnci.2014.01.001_b0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1746.2009.05988.x","article-title":"Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers","volume":"25","author":"Tangkijvanich","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jnci.2014.01.001_b0195","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(09)70241-4","article-title":"Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Poon","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jnci.2014.01.001_b0200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3748\/wjg.v16.i4.418","article-title":"Present and future possibilities for early diagnosis of hepatocellular carcinoma","volume":"16","author":"Stefaniuk","year":"2010","journal-title":"World J Gastroenterol"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S111003621400003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S111003621400003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:15:12Z","timestamp":1597450512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S111003621400003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S111003621400003X"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2014.01.001","relation":{},"ISSN":["1110-0362"],"issn-type":[{"value":"1110-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Egyptian National Cancer Institute","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnci.2014.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}